New treatment destroys head and neck cancer tumours in UK trial
Scientists found that combining nivolumab and ipilimumab medications led to a reduction in the size of tumours in terminally ill head and neck cancer patients
The cancer vanished in some patients altogether, with doctors stunned to find no detectable sign of disease
When the research nurses called to tell me that, after two months, the tumour in my throat had completely disappeared, it was an amazing moment.
Barry Ambrose
Cancer patient and study participant
These are promising results. Immunotherapies are kinder, smarter treatments that can bring significant benefits to patients.
Prof Kristian Helin
Chief executive
Institute for Cancer Research